Table 5 Prevalence of pre-diabetes by type of drug chelation & other parameters
N | FBG < 100 | 100 ≤ FBG < 126 | Chi-square | p-value | |||
|---|---|---|---|---|---|---|---|
n | % | n | % | ||||
Age group | |||||||
2–9 | 2 | 2 | 100.0 | 0 | 0.0 | 0.696 | 1.000 |
10–18 | 46 | 34 | 73.9 | 12 | 26.1 | ||
Gender | |||||||
Male | 24 | 18 | 75.0 | 6 | 25.0 | 0.000 | 1.000 |
Female | 24 | 18 | 75.0 | 6 | 25.0 | ||
Nationality | |||||||
UAE | 24 | 19 | 79.2 | 5 | 20.8 | 0.895 | 0.639 |
Arabs | 9 | 6 | 66.7 | 3 | 33.3 | ||
Non-Arabs | 12 | 8 | 66.7 | 4 | 33.3 | ||
BMI | |||||||
< 18.5 | 17 | 14 | 82.4 | 3 | 17.6 | 0.932 | 0.628 |
18.5–24.9 | 26 | 18 | 69.2 | 8 | 30.8 | ||
>=25.0 | 4 | 3 | 75.0 | 1 | 25.0 | ||
DFO (Deferoxamine) Chelation Drug | |||||||
No | 41 | 31 | 75.6 | 10 | 24.4 | 0.056 | 1.000 |
Yes | 7 | 5 | 71.4 | 2 | 28.6 | ||
DFP (Deferiprone) Chelation Drug | |||||||
No | 46 | 34 | 73.9 | 12 | 26.1 | 0.696 | 1.000 |
Yes | 2 | 2 | 100.0 | 0 | 0.0 | ||
DFX (Deferasirox) Chelation Drug | |||||||
No | 6 | 5 | 83.3 | 1 | 16.7 | 0.254 | 1.000 |
Yes | 42 | 31 | 73.8 | 11 | 26.2 | ||